Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,313.48
+8.49
(+0.26%)
Nikkei
38,787.38
-132.88
(-0.34%)
Hang Seng
19,553.61
+177.08
(+0.91%)
FTSE 100
8,420.26
-18.39
(-0.22%)
Bitcoin USD
67,187.54
+59.30
(+0.09%)
CMC Crypto 200
1,368.90
-4.94
(-0.36%)
Ascendis Pharma A/S (ASND)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
121.12
-1.68
(-1.37%)
At close: 04:00PM EDT
123.72
+2.60
(+2.15%)
After hours:
06:34PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
Currency in EUR.
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
329,023
266,718
51,174
7,778
6,953
Cost of revenue
47,343
44,395
12,137
3,523
0
Gross profit
281,680
222,323
39,037
4,255
6,953
Operating expenses
Research development
378,027
413,454
379,624
295,867
260,904
Selling general and administrative
264,654
264,410
221,227
160,180
76,669
Total operating expenses
642,681
677,864
600,851
456,047
337,573
Operating income or loss
-361,001
-455,541
-561,814
-451,792
-330,620
Interest expense
111,386
44,065
30,682
3,911
1,918
Total other income/expenses net
4,036
8,605
7,253
71,067
-88,448
Income before tax
-493,054
-474,144
-577,817
-383,944
-419,174
Income tax expense
8,514
7,303
5,377
-367
-219
Income from continuing operations
-501,568
-481,447
-583,194
-383,577
-418,955
Net income
-501,568
-481,447
-583,194
-383,577
-418,955
Net income available to common shareholders
-501,568
-481,447
-583,194
-383,577
-418,955
Basic EPS
-10.72
-8.55
-10.40
-7.00
-8.28
Diluted EPS
-10.72
-8.55
-10.40
-7.00
-8.28
Basic average shares
56,131
56,287
56,072
54,772
50,617
Diluted average shares
56,131
56,287
56,072
54,772
50,617
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.